ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Peng Xie
Matched on ORCID iD 0000-0002-5739-2485; OpenAlex author ID A5086544171. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 22
2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 1 paper
Papers 4
- Tumor-Derived Interleukin 35 Promotes Fibrosis in the Tumor Microenvironment of Pancreatic Cancer by Activating Pancreatic Stellate Cells. Co-author DOI 10.1002/advs.202509074↗
- Transcriptomic landscape of endothelial cells: Key tumor microenvironment components indicating variable clinical outcomes in pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/tox.23881↗
- BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism. Co-author DOI 10.1126/sciadv.adj8650↗
- CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Independent Mechanism. Co-author DOI 10.1002/advs.202206335↗
Closest collaborators
The 22 strongest of 22 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chongbiao Huang · 3 shared papers, 2023–2026 · strength 0.56
- Paper Tumor-Derived Interleukin 35 Promotes Fibrosis in the Tumor Microenvironment of Pancreatic Cancer by Activating Pancrea… DOI 10.1002/advs.202509074↗
- Paper BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism. DOI 10.1126/sciadv.adj8650↗
- Paper CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Ind… DOI 10.1002/advs.202206335↗
- Jihui Hao · 3 shared papers, 2023–2026 · strength 0.56
- Paper Tumor-Derived Interleukin 35 Promotes Fibrosis in the Tumor Microenvironment of Pancreatic Cancer by Activating Pancrea… DOI 10.1002/advs.202509074↗
- Paper BICC1 drives pancreatic cancer stemness and chemoresistance by facilitating tryptophan metabolism. DOI 10.1126/sciadv.adj8650↗
- Paper CD73, a Promising Therapeutic Target of Diclofenac, Promotes Metastasis of Pancreatic Cancer through a Nucleotidase Ind… DOI 10.1002/advs.202206335↗
- Chao Xu · 2 shared papers, 2024–2026 · strength 0.42
- Hui Li · 2 shared papers, 2024–2026 · strength 0.42
- Yukuan Feng · 2 shared papers, 2024–2026 · strength 0.42
- Huizhi Sun · 2 shared papers, 2024–2026 · strength 0.42
- Siyuan Tan · 1 shared paper, 2024 · strength 0.28
- Haifeng Li · 1 shared paper, 2024 · strength 0.28
- Jiahua Zhou · 1 shared paper, 2024 · strength 0.28
- Haodong Tang · 1 shared paper, 2024 · strength 0.28
- Wei Lin · 1 shared paper, 2026 · strength 0.25
- Shengyu Yang · 1 shared paper, 2024 · strength 0.17
- Danqi Fu · 1 shared paper, 2024 · strength 0.17
- Xiuchao Wang · 1 shared paper, 2024 · strength 0.17
- Song Gao · 1 shared paper, 2024 · strength 0.17
- Tiansuo Zhao · 1 shared paper, 2024 · strength 0.17
- Jing Liu · 1 shared paper, 2024 · strength 0.17
- Chao Wu · 1 shared paper, 2023 · strength 0.14
- Shengnan Li · 1 shared paper, 2023 · strength 0.14
- Bo Tang · 1 shared paper, 2023 · strength 0.14
- Weishuai Liu · 1 shared paper, 2023 · strength 0.14
- Xiaozhou Yu · 1 shared paper, 2023 · strength 0.14
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.